thalidomide has been researched along with Metabolism, Inborn Errors in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kernis, MM | 1 |
| Kirchmair, H | 1 |
1 review available for thalidomide and Metabolism, Inborn Errors
| Article | Year |
|---|---|
Principles of teratology.
Topics: Abnormalities, Drug-Induced; Amniocentesis; Animals; Chromosome Aberrations; Chromosome Disorders; C | 1972 |
2 other studies available for thalidomide and Metabolism, Inborn Errors
| Article | Year |
|---|---|
Abstracts of papers presented at the eighteenth annual meeting of the Congenital Anomalies Research Association of Japan Yokohama, Japan July 13-14, 1978.
Topics: Animals; Chromosomes; Congenital Abnormalities; Congresses as Topic; Disease Models, Animal; Humans; | 1978 |
[Congenital metabolic diseases--thalidomide embryopathies].
Topics: Abnormalities, Drug-Induced; Animals; Child; Germany, West; Humans; Metabolism, Inborn Errors; Rabbi | 1968 |